Objective: To investigate changes in human atrial single cell functional electrophysiological properties associated with chronic atrial fibrillation (AF), and the contribution to these of accompanying ion current changes. Methods: The whole cell patch clamp technique was used to record action potentials, the effective refractory period (ERP) and ion currents, in the absence and presence of drugs, in enzymatically isolated myocytes from 11 patients with chronic (.6 months) AF and 39 patients in sinus rhythm. Results: Stimulation at high rates (up to 600 beats / min) markedly shortened late repolarisation and the ERP in cells from patients in sinus rhythm, and depolarised the maximum diastolic potential (MDP). Chronic AF was associated with a reduction in the ERP at physiological rate (from 203616 to 104615 ms, P,0.05), and marked attenuation in rate effects on the ERP and repolarisation. The abbreviated terminal phase of rhythm with nifedipine (10 micromol / l) moderately shortened repolarisation, but had no effect on the ERP (228612 vs. 225611 ms). 4-Aminopyridine (2 mmol / l) markedly prolonged repolarisation and the ERP (by 35%, P,0.05). However, the combination of these drugs had no effect on late repolarisation or refractoriness. Conclusion: Chronic AF in humans is associated with attenuation in adaptation of the atrial single cell ERP and MDP to fast rates, which may not be explained fully by accompanying changes in I and CaL I .
The ERP is largely determined by the duration of final Patients and I [12, 13] are also reduced in AF, due to ion channel MVR  0  0  5  45   TO   AVR1MVR  0  0  2  18 transcriptional down-regulation [14, 15] . However, the pat- I are conflicting [12, 15] During AF, the atria generally activate at rates .400 beats per min (bpm), and may reach 600 bpm [16] . currently lacking. We aimed to investigate, in human atrial isolated myocytes, changes in functional electrophysiological propchunk method, described in detail previously by Harding et erties associated with chronic AF (including rate adaptaal. [18] and Escande et al. [19] . Briefly, excised tissue tion of the ERP and membrane potential) and, with (weight: 0.2560.02 g) was sliced into chunks and shaken pharmacological modulation, the contribution to these (130 strokes / min) at 378C, under O , in a nominally 2 21 changes of observed alterations in ion currents.
Ca -free solution, containing (mM) NaCl (120.0), KCl 2. Methods transfer to fresh Ca -free solution every 3 min. Protease (Type XXIV, Sigma, 4 U / ml) and CaCl (50 mM) were 2 2.1. Cardiac myocyte isolation added, and tissues were shaken for a further 45 min. The protease was then substituted by collagenase (Type 1, The tip of the right atrial appendage was obtained from Worthington, 400 U / ml), and partially digested tissues 50 patients undergoing cardiac surgery, whose characteriswere incubated for consecutive periods of 15, 15 and 20 tics are shown in Table 1 . Procedures approved by the min. The cell suspension obtained after each incubation institutional research ethics committee were followed, and was filtered through nylon gauze (200 mm mesh, Barr & each patient's informed consent was obtained. The inWray, Lanark, UK) and centrifuged at 40 g for 2 min. The vestigation conforms with the principles outlined in the supernatant was removed and cells centrifuged again after 1 21 Declaration of Helsinki [17] . The tissue was transported to their resuspension in 1 ml of a high [K ], low [Ca ] the laboratory for processing within 5 min of excision.
solution ('KB' [20] ), to wash off residual enzymes. Atrial cells were isolated by enzymatic dissociation and Finally, the KB was replaced with a 0.2 mM CaCl -2 mechanical disaggregation, using a modification of the containing physiological salt solution for the independent storage in petri-dishes of the three cell fractions, for up to The ERP was measured using a standard S -S stimula- was used both to stimulate and record electrical activity. currents were measured at the end of 500 ms duration Current and voltage signals were low pass filtered at 5 kHz pulses (0.33 Hz), increasing in 10 mV steps from 2120 mV, and digitised (Digidata 1200 A-D converter, Axon Instruwith a holding potential of 240 mV. When superfusing ments) prior to storage on magnetic and compact discs. cells with drugs, ion currents, action potentials and / or the ERP were recorded 90 s after drug addition, and again at 2.3. Experimental protocols 90 s intervals after drug removal until the reversal of any drug effect was confirmed. Action potentials were stimulated at various rates (75-600 bpm) using 5 ms current pulses of 1.23threshold strength, after current clamping resting cells at 275 mV 2.4. Data analysis and statistics and keeping the holding current constant thereafter. Only those cells which required a holding current of ,150 pA Patients were grouped according to their cardiac rhythm immediately after establishing the whole cell configuration at the time of surgery. Only those in SR, or in AF which were used, and this frequently could be reduced following had persisted for at least the previous 6 months, were stimulation with a train of depolarising pulses, as reported included. Patient data were analysed using Access software previously in human atrial cells [22] . In subsequent action (Microsoft), and voltage and current data, using WinWCP. potential recordings, there was no significant difference in I and action potential data were included only if the CaL the holding current between the groups of patients with SR post cell-access time was #10 min, to avoid distortion by and AF, at 26666 and 264619 pA (n512 and 11 current 'run-down'. Cells were included for APD or ERP patients), respectively. The stimulus threshold current analysis only if the control APD was #290 ms, con-90 amplitude was initially determined in each cell by stimulatsistent with Type 3 human atrial cells [23] . All currents ing repetitively with trains of three current pulses, the 1st were normalised to the cell's capacity. Values (means1 and 2nd being of equal, suprathreshold amplitude, and the S.E.M.) were compared using two-tailed paired or unpaired 3rd pulse increasing progressively (from zero, in steps of Student's t tests, as appropriate. P,0.05 was regarded as 50 pA) until it produced a regenerative action potential. statistically significant.
Results
late repolarisation, with, for example, a 39% shortening in APD upon increasing from 75 to 300 bpm stimulation. 90 
Fast rate-induced depolarisation and APD-
By contrast, in the cell from the patient with chronic AF shortening was attenuated in cells from patients with AF ( Fig. 1 , right hand panel), increasing the stimulation rate to 300 bpm produced a negligible change in the MDP, since Fig. 1 shows that at the physiological rate of 75 bpm the final phase of repolarisation of the post-rest action (top traces), action potentials recorded from a single atrial potential was sufficiently abbreviated in this cell not to be cell isolated from a patient with chronic AF displayed a encroached upon by the reduced basic cycle length at this markedly different morphology to those recorded in a cell rate. Furthermore, even at rates as high as 600 bpm, such from a patient in SR. Repolarisation was more linear in as these cells might have encountered in-vivo, the degree form than in the cell from the SR patient, with a less of MDP depolarisation was smaller than that seen in the pronounced phase 1 and a markedly shorter late repolarisacell from the patient in SR. tion. When the stimulation rate was increased to 300 bpm Fig. 2 shows mean action potential data which con-(cycle length: 200 ms) in the cell from the patient in SR firmed that, at the physiological rate of 75 bpm, chronic (Fig. 1, left hand panel) , the upstroke of the second and AF was associated with a marked and significant abbreviasubsequent action potentials impinged on the final stages tion in late (APD ), but not in early (APD ) repolarisa- tentials. This prevented full recovery of the resting pobetween cells, particularly in those from patients in SR, tential following each response, causing depolarisation of owing to the high sensitivity of this measurement to the the maximum diastolic potential (MDP). This depolarising height of the end of phase 1. The mean data also confirmed effect became more pronounced as the rate was increased that increases in rate to 300 bpm and higher in cells from further, was marked at the fastest rates encountered during AF (i.e. up to 600 bpm) and was fully reversible upon returning to 75 bpm (bottom trace). Despite such depolarisation at the highest rates, regenerative responses occurred but with reduced action potential amplitude (63 mV). This was substantially higher than that of the electrotonic ('just subthreshold') responses (17 mV) measured at the start of the experiment. The stepwise increase in rate was accompanied by a progressive reduction in steady-state APD at patients in SR produced both substantial shortening in late repolarisation, and depolarisation of the MDP (panel B). By contrast, in the cells from the patients with chronic AF, whilst a small depolarisation of the MDP and shortening in APD were evident at supraphysiological rates (Fig. 2) , 90 the rate adaptation in these measurements was clearly markedly attenuated in comparison with that seen in the cells from the patients in SR.
Atrial cell ERP was shortened and its rate adaptation attenuated in myocytes from AF patients
The human atrial cell ERP was measured initially at the physiological basic rate of 75 bpm, as shown in the upper trace of Fig. 3A , by the superimposed action potentials recorded in a single cell obtained from a patient in SR. A four-fold increase in the stimulation rate in this cell produced a marked reduction in the ERP, from 200 to 140 ms, as shown in the trace beneath. This effect was fully reversible upon returning to 75 bpm stimulation. By contrast, in a single cell obtained from a patient with chronic AF, the ERP was dramatically abbreviated at the physiological rate. Moreover, an increase in the rate to 300 bpm produced only a small degree of further ERP-shortening, of 20 ms (Fig. 3A, lower trace pair) . The high time resolution of these ERP recordings permitted accurate measurement of the maximum upstroke velocity, V , change in the Ca current included a potentially interfering influence from outward currents, but this was minimised by the subtraction of end-pulse currents from peak I . The trace beneath shows that a four-fold increase in CaL rate, in the same cell, produced a rapid and substantial reduction in steady-state I . In a cell from a patient with CaL AF (Fig. 4B, lower trace pair) , both the post-rest and steady-state I amplitudes were markedly smaller at 75
CaL bpm, than in the cell from the patient in SR. However, the effect of rate increase was similar in both cell types, with a diminution of I at supraphysiological rates. Fig. 4C CaL shows mean data, including rates of up to 600 bpm, which confirmed these changes and indicated that the contribution of the reduction in I associated with chronic AF would CaL be smaller at physiological rates and higher, than at sub physiological rate.
I was reduced, I was unaltered and I was TO KSUS K1 increased in atrial cells from patients in AF
Fig . 5A shows that the rapidly activating, transient outward currents evoked by voltage pulses to between 110 and 160 mV, which represent I , were markedly reduced TO in amplitude in a cell isolated from a patient with chronic AF, compared with those recorded in a cell from a patient in SR. In contrast, the steady-state (end-pulse) currents, I
, were similar in both cells. The mean I and I
KSUS KSUS TO
density-voltage relationships were calculated, from the end pulse currents and by subtraction of these from the transient peaks at each voltage step, respectively. These confirmed that chronic AF was associated with a marked and significant reduction in I , by 65% ( [12], and consistent with the low resting potential typically observed in these cells. Nevertheless, the slope of the of voltage pulses delivered at 75 bpm in a cell from a current-voltage relationship between 2120 and 2100 mV patient in SR. There was an immediate and progressive indicated that it was largely representative of I . This .05, n54) . Fig. 6A shows the corresponding effects on action potentials and the ERP at physiological rate, in an atrial cell isolated from a patient in SR. Nifedipine had no effect on early repolarisation, but produced a small reduction in the plateau (left hand panel of Fig. 6A ) accompanied by a shortening in APD and 75 APD , but with little effect, however, on final repolarisa-90 tion. The right hand panel of Fig. 6A shows that in the same cell, the ERP was hardly affected by nifedipine, with a shortening of 10 ms. Table 2 shows mean data which AF [8] . However, the reduction in late repolarisation was ERP 221610 (18) 225611 (11) 282619 (5)* 21064 (4) similar to that reported in human atrial cells [12] .
Nif5nifedipine (10 mmol / l), 4-AP54-aminopyridine (2 mmol / l).
Rates up to 600 bpm caused marked adaptation of both reported in atrial trabeculae from dogs [26] and humans *5P,0.05 vs. corresponding control group (paired t-test). [23, 27] at up to 270 bpm, but in human atrial cells, neither higher rates, effects of rate on the MDP, nor associated effects of AF, were reported [11, 12] . Our data suggest that confirmed that, in cells from patients in SR, I
inhibition, in unremodelled atrial cells exposed to sufficiently high CaL which had no effect on the MDP or APD , produced a rate, as might occur during paroxysmal AF, depolarisation 50 small but statistically significant reduction in both APD of the MDP may result. This is consistent with the The left hand panel of Fig. 6B shows that 4-AP suppressed potential, largely attenuated such depolarisation, even at phase 1 and substantially prolonged subsequent repolarisathe highest rates encountered during AF [16] . In the canine tion. The right hand panel of Fig. 6B shows that 4-AP also model, AF also attenuated depolarisation [26] . These produced a marked lengthening in the ERP in a single cell, results support the notion that remodelling may be a by 60 ms. Mean data confirmed these drug effects, with a cellular adaptive response to keep the APD short, and thus 21 marked and significant prolongation of all levels of oppose Ca overload, but at the expense of reentryrepolarisation, and of the ERP by 33% (Table 2) . Fig. 6C promoting ERP-shortening. illustrates the actions of the combination of 10 mmol / l
We demonstrated a marked rate-dependent reduction in nifedipine and 2 mmol / l 4-AP in an atrial cell from a I , consistent with a contribution to the APD rate CaL patient in SR. The left hand panel shows that whilst phase response. Chronic AF was associated with a substantial 1 was suppressed, in contrast with the effects of 4-AP on reduction (by 60-65%) in the fully reactivated I and CaL its own, subsequent repolarisation was not prolonged. I , with no alteration in their voltage-dependency. The TO Indeed, there was a slight shortening effect on late peak density of these currents in cells from patients in SR, repolarisation in this cell. However, the ERP, recorded in and the magnitude of their reduction associated with AF, the same cell (Fig. 6C, right hand 4. Discussion associated with AF in one study [12] , but an increase in I K1 in left, but not right, atrial cells has also been reported The ERP was measured, for the first time to our [15] , and there was an absence of change in I in canine K1 knowledge in human atrial isolated myocytes, and both its atria [2] . The lack of a substantial change in I over K1 value at physiological rate and its adaptation to an increase physiological potentials in the present study suggested only in rate were in close agreement with those recorded in the a limited involvement of this current in the shortening of right atrium of patients, including the appendage APD and ERP. Human atrial I includes the rapidly and K slowly activating currents, I and I , respectively [29] , coronary revascularisation only. Mitral valve disease is [23, 27] , and those with extremeand without chronic AF, consistent with a lack of alteration ly prolonged repolarisation [23] have also been reported, 1 in the Na current density reported in human atrium [12] . and these could have differing ERP and MDP rate reIn cells from patients without AF, nifedipine signifisponses, potentially contributing to electrical heterogenecantly shortened the action potential, particularly at around ity. Additionally, the ERP was recorded in the absence of 75% repolarisation. This indicated an important contributhe electrotonic influences and structural and electrophytion of I to the APD and its rate adaptation In conclusion, chronic AF in humans is associated with presumably by prolonging the plateau and consequently shortening, and attenuation in rate adaptation, of the ERP 1 enhancing voltage-dependent K currents [33] , but this in single atrial cells. The accompanying abbreviation in was also only reported at low rate (6 bpm) [2] . Moreover, late repolarisation may largely prevent excessive depolarthe combination of nifedipine and 4-AP, despite prolonging isation at high rates. Associated alterations in I and I CaL TO early repolarisation at physiological rate, had no significant are probably insufficient to fully account for such changes. effect on either late repolarisation or the ERP. Thus, the Our data may have important implications in the potential simultaneous reduction in atrial I and I associated therapeutic modulation of AF-induced electrophysiological CaL TO with human AF may not be sufficient to fully account for remodelling. the marked shortening in late repolarisation and ERP which results from this arrhythmia. In support, a recent mathematical model [34] suggested that AF-induced re
